| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.005 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.1 | 0.006 |
| mRNA | tubastatin A | CTRPv2 | pan-cancer | AAC | 0.14 | 0.006 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.079 | 0.006 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | 0.093 | 0.008 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | 0.13 | 0.009 |
| mRNA | QL-XI-92 | GDSC1000 | pan-cancer | AAC | -0.083 | 0.009 |
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.009 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.15 | 0.009 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | 0.14 | 0.01 |